What causes testosterone insensitivity affecting penile size in adult men?

Testosterone Insensitivity and Penile Size in Adults

Testosterone insensitivity affecting penile size in adult men is caused by mutations in the androgen receptor gene, resulting in androgen insensitivity syndrome (AIS), which manifests as reduced or absent response of target tissues to testosterone despite normal or elevated testosterone levels. 1

Primary Mechanism: Androgen Receptor Dysfunction

The fundamental cause is reduced testosterone-androgen receptor interaction due to genetic defects in the androgen receptor (AR) gene located on the X chromosome. 1, 2 This creates a spectrum of clinical presentations:

Complete Androgen Insensitivity Syndrome (CAIS)

• Results in complete resistance to testosterone action despite normal male testosterone production 2, 3
• Individuals with 46,XY karyotype develop female external phenotype with absent or minimal virilization 4, 2
• Characterized by normal or elevated testosterone and LH levels, but tissues cannot respond 3, 5

Partial Androgen Insensitivity Syndrome (PAIS)

• Produces variable degrees of undervirilization in genetic males 5, 6
• Can present with ambiguous genitalia, micropenis, or reduced penile development 5, 6
• Testosterone levels are typically elevated with high LH, reflecting the body's attempt to overcome receptor resistance 5

Mild Androgen Insensitivity Syndrome

• The most relevant form for your question about adult penile size 7
• Presents with normal male body habitus but reduced penile length, gynecomastia, small prostate, and often infertility 7
• Laboratory findings show elevated testosterone and LH levels despite the male phenotype 7
• Genital skin fibroblast studies demonstrate decreased dihydrotestosterone-binding capacity 7
• Some patients have normal receptor binding levels, suggesting post-receptor defects in androgen action 7

Congenital vs. Acquired Causes

Congenital Disorders (Primary Causes)

The 2025 EAU guidelines classify these as congenital or developmental disorders: 1

• Partial or complete androgen insensitivity (most common genetic cause)
• 5α-reductase type II deficiency (prevents conversion of testosterone to more potent dihydrotestosterone)
• Aromatase deficiency
• Kennedy disease (spinal and bulbar muscular atrophy with CAG repeat extensions)

Drug-Induced Androgen Insensitivity

Medications can block androgen receptors and create acquired insensitivity: 1

• Steroidal antiandrogens (cyproterone acetate, spironolactone)
• Nonsteroidal antiandrogens (flutamide, bicalutamide, nilutamide)
• 5α-reductase inhibitors (finasteride, dutasteride)

Clinical Correlation: Penile Size and Testosterone

Important caveat: In adults with established penile development, testosterone insensitivity does not cause penile shrinkage but rather reflects inadequate androgenization during critical developmental periods (fetal life and puberty). 7, 8

Research demonstrates that:

• Penile growth is strongly testosterone-dependent during puberty, with a weak positive correlation between testosterone levels and penile size (r=0.20-0.24) 8, 9
• Reduced penile length in adults reflects developmental testosterone exposure deficits, not current adult testosterone levels 9
• Adult testosterone levels may be normal or even elevated in men with shorter penile length from developmental androgen insensitivity 9

Diagnostic Approach

When evaluating suspected testosterone insensitivity affecting penile development: 1

Laboratory Testing:

• Measure early morning total testosterone on two separate occasions (diagnosis requires levels consistently <300 ng/dL for hypogonadism, but AIS shows normal/elevated levels) 1
• Measure serum LH levels - elevated LH with normal/high testosterone suggests receptor resistance 1, 5
• Calculate LH × testosterone product - markedly elevated in androgen insensitivity 5
• Assess testosterone-to-dihydrotestosterone ratio if 5α-reductase deficiency suspected 7

Genetic Testing:

• Karyotype analysis to identify 46,XY in phenotypically female or undervirilized individuals 4, 3
• Androgen receptor gene sequencing for definitive diagnosis 2, 6
• Genital skin fibroblast studies showing decreased dihydrotestosterone-binding capacity confirms receptor dysfunction 7

Physical Examination Findings:

• Reduced penile length with otherwise normal male habitus 7
• Gynecomastia (common in mild AIS) 7
• Small prostate size 7
• Decreased or absent body/pubic hair in complete forms 3

Critical Clinical Pitfall

The most common error is assuming that adult testosterone supplementation will increase penile size in men with developmental androgen insensitivity. 9 Once skeletal maturity is reached, testosterone therapy cannot reverse the effects of inadequate androgenization during critical developmental windows. The reduced penile length represents a permanent marker of developmental androgen insufficiency or resistance, not a reversible condition. 7, 9